SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-038609
Filing Date
2023-05-11
Accepted
2023-05-11 17:16:48
Documents
85
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_allarityther.htm   iXBRL 10-Q 796989
2 CERTIFICATION f10q0323ex31-1_allarity.htm EX-31.1 8181
3 CERTIFICATION f10q0323ex31-2_allarity.htm EX-31.2 8346
4 CERTIFICATION f10q0323ex32-1_allarity.htm EX-32.1 4208
5 CERTIFICATION f10q0323ex32-2_allarity.htm EX-32.2 3953
  Complete submission text file 0001213900-23-038609.txt   5424723

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE allr-20230331.xsd EX-101.SCH 71218
7 XBRL CALCULATION FILE allr-20230331_cal.xml EX-101.CAL 37086
8 XBRL DEFINITION FILE allr-20230331_def.xml EX-101.DEF 291302
9 XBRL LABEL FILE allr-20230331_lab.xml EX-101.LAB 549602
10 XBRL PRESENTATION FILE allr-20230331_pre.xml EX-101.PRE 314651
79 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_allarityther_htm.xml XML 542350
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 23912232
SIC: 2834 Pharmaceutical Preparations